Submitted by reuters8361 in business
All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health program, including Amgen <a href="https://www.reuters.com/markets/companies/AMGN.O" target="_blank">(AMGN.O)</a> and Novartis …